As it does each September during Newborn Screening Awareness Month, Baby’s First Test is sharing information and stories that…
Mary Chapman
Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Mary Chapman
Raising Awareness of Fabry Disease
Raising awareness of rare chronic disorders such as Fabry disease could mean more patients benefiting from earlier diagnosis…
What Do Blood Test Results Mean in Fabry Disease?
There are various blood tests that doctors can use to diagnose Fabry disease, a progressive genetic disorder caused…
The EveryLife Foundation for Rare Diseases has launched a scholarship fund in the U.S. to support individuals with rare…
Mindfulness for Fabry Disease Patients
It can be very stressful — and dispiriting — to live with a rare chronic disorder such as Fabry…
Creating a Treatment Plan for Fabry Disease
Because Fabry disease affects multiple organs, patients are well advised to keep a comprehensive and personal treatment plan. Here’s…
The Spoon Theory and Fabry Disease
Fabry disease can lead to problems at home, school, work, and everyday life. The disorder affects your whole body…
The Rare Diseases Clinical Research Network (RDCRN) has opened an online survey to better understand how the…
The National Organization for Rare Disorders (NORD) has opened a financial assistance program for people in rare disease community…
Axovant Gene Therapies is collaborating with Invitae to offer free genetic testing in the United States and Canada…